Years of Rewards: $34 Bil From Eli Lilly Stock

LLY: Eli Lilly logo
LLY
Eli Lilly

In the last five years, Eli Lilly (LLY) stock has returned $34 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let’s look at some numbers and compare how this payout power stacks up against the market’s biggest capital-return machines.

As it turns out, LLY stock has returned the 51st highest amount to shareholders in history.

  LLY S&P Median
Dividends $22 Bil $3.0 Bil
Share Repurchase $12 Bil $3.0 Bil
Total Returned $34 Bil $6.0 Bil
Total Returned as % of Current Market Cap 3.8% 17.1%

Why should you care? Because dividends and share repurchases represent direct, tangible returns of capital to shareholders. They also signal management’s confidence in the company’s financial health and ability to generate sustainable cash flows. And there are more stocks like that. Here is a list of the top 10 companies ranked by total capital returned to shareholders via dividends and stock repurchases.

Top 10 Stocks By Total Shareholder Return

Relevant Articles
  1. Cash Rich, Low Price – CDW Stock to Break Out?
  2. Costco Wholesale Stock Capital Return Hits $20 Bil
  3. Arista Networks Stock Hits Key Support – Buying Opportunity?
  4. Humana Stock Near Crucial Support – Buy Signal?
  5. Booking Stock Delivers Strong Cash Yield – Upside Ahead?
  6. SMCI Looks Smarter Buy Than Hewlett Packard Enterprise Stock

  Total Money Returned As % Of Current Market Cap via Dividends via Share Repurchases
AAPL $508 Bil 11.7% $76 Bil $432 Bil
GOOGL $288 Bil 6.1% $20 Bil $268 Bil
MSFT $223 Bil 7.4% $108 Bil $115 Bil
JPM $181 Bil 21.8% $72 Bil $108 Bil
XOM $157 Bil 24.8% $79 Bil $78 Bil
META $156 Bil 10.2% $12 Bil $145 Bil
BAC $129 Bil 35.0% $45 Bil $84 Bil
CVX $116 Bil 31.4% $58 Bil $57 Bil
WFC $108 Bil 46.6% $23 Bil $85 Bil
NVDA $96 Bil 1.8% $3.0 Bil $93 Bil

For full ranking, visit Buybacks & Dividends Ranking

What do you notice here? The total capital returned to shareholders as a % of the current market cap appears inversely proportional to growth prospects for reinvestments. Stocks like Meta (META) and Microsoft (MSFT) are growing much faster, in a more predictable way, compared to the others, but they have returned a much lower fraction of their market cap to shareholders.

That’s the flip side to high capital returns. Sure, they are attractive, but you have to ask yourself the question: Am I sacrificing growth and sound fundamentals?

Eli Lilly Fundamentals

  • Revenue Growth: 47.4% LTM and 37.9% last 3-year average.
  • Cash Generation: Nearly 14.4% free cash flow margin and 47.3% operating margin LTM.
  • Recent Revenue Shocks: The minimum annual revenue growth in the last 3 years for LLY was 29.8%.
  • Valuation: Eli Lilly stock trades at a P/E multiple of 35.0

  LLY S&P Median
Sector Health Care
Industry Pharmaceuticals
PE Ratio 35.0 23.5

   
LTM* Revenue Growth 47.4% 7.4%
3Y Average Annual Revenue Growth 37.9% 5.7%
Min Annual Revenue Growth Last 3Y 29.8% 0.8%

   
LTM* Operating Margin 47.3% 18.4%
3Y Average Operating Margin 39.7% 18.3%
LTM* Free Cash Flow Margin 14.4% 14.4%

*LTM: Last Twelve Months

The table gives a good overview of what you get from LLY stock vs median S&P 500, but comparing against its own peers is just as important.

LLY Historical Risk

There is no free lunch. When it comes to buybacks and dividends, shareholders get rewarded for “staying invested”. And that is not easy. Even the strongest conviction gets tested during volatile market phases, and is best illustrated by understanding how low LLYstock has fallen during the past market crises.

Staying Invested Matters If You Want Returns

Staying invested in markets is the only way to get returns. The mechanism does not matter. Whether it is fundamental price appreciation, share buybacks or dividends, the market does not reward you for watching from the sidelines. So how do you invest, and stay invested? Simple. Through “Portfolio” approach.

The Trefis High Quality Portfolio (HQ) Portfolio is designed to keep you in the game. By spreading your exposure across 30 quality stocks, it neutralizes the “all-or-nothing” risk of a single stock. It dampens the sharp, stomach-churning drops while maintaining upside exposure.